Navigation Links
Thera Max™ Cold and Flu Debuts in Times Square During the Height of the 2011 / 2012 Holiday Season
Date:12/13/2011

NEW YORK, Dec. 13, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, announced today that the Company's Thera Max™ Cold and Flu product will be prominently displayed on a billboard ad in Times Square at 42nd Street between 7th and 8th Avenues as part of the Company's ongoing product marketing program.

The Thera Max™ ad will run from December 15, 2011 through January 15, 2012 and will be seen by millions of people traveling through Times Square this holiday season.

Kelly Hickel, CEO of TheraBiogen, commented, "Our Times Square billboard provides significant exposure for the Thera Max™ brand through New Year's Eve and into 2012 as we continue to seek timely marketing opportunities to benefit our customers and ultimately our shareholders."

Thera Max™ Cold and Flu is an all-natural, non-zinc, non-addictive, over-the-counter cold flu relief agent.  Over 50 million Americans contract the flu each year and consumer demand for a homeopathic, non-zinc remedy is a 2.5 billion dollar market.

Thera Max™ is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts, Big Y Supermarkets and other major retailers.  For more information on Thera Max™ visit our website at www.theramaxrelief.com, our  Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.

About TheraBiogen, Inc.TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, whic
'/>"/>

SOURCE TheraBiogen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease
3. UKs National Health System Rejects Drug Therapy for Diabetic Macular Edema
4. S*BIOs Novel JAK2 Inhibitor Pacritinib (SB1518) Effectively Reduces Splenomegaly in Myelofibrosis (MF) Patients With Minimal Impact on Existing Cytopenias Providing Important Therapeutic Niche In Treatment of MF
5. Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
6. 10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
7. Genetic and Proteomic Advances Pave the Way for Next-Generation Leukemia Therapies
8. Elektas Leksell Gamma Knife Perfexion Earns Nearly Perfect Score in 2011 KLAS Radiation Therapy Report
9. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
10. NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors
11. Future Therapeutic Drug Monitoring Market: US, Europe, Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... 2010 Abbott Diabetes Care today announced that it ... million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® ... Strips in the United States and Puerto Rico. ... Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium and ...
... 2010 Heska Corporation (Nasdaq: HSKA ) announces ... to Its Special Meeting of Stockholders on the WebWhen: , ... (click on the Special Meeting of Stockholders link on ... Internet -- Simply log on to the web at the ...
Cached Medicine Technology:Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico 2Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico 3Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico 4Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico 5Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico 6Webcast Alert: Heska Corporation's Special Meeting of Stockholders Webcast 2
(Date:4/22/2014)... are more likely to have a child who develops ... A recent study from researchers from the Drexel University ... in Sweden provides more insight into how the risk ... ages, and found that the risk of having a ... for older parents., In the study, published in the ...
(Date:4/22/2014)... Based on results of a clinical trial led ... and Drug Administration (FDA) approved a molecularly targeted ... that has progressed after standard chemotherapy has failed. ... was announced by the manufacturer, Lilly Oncology, of ... ramucirumab, it will be sold under the name ...
(Date:4/22/2014)... identify patients who are at highest risk for respiratory ... condition, suggest data from a large multi-center study published ... Affecting nearly 200,000 Americans a year, acute respiratory distress ... caused by a number of issues ranging from smoke ... develop ARDS after surgery. ARDS is difficult to treat ...
(Date:4/22/2014)... out of the University of Calgary,s Hotchkiss Brain Institute ... nerve cells as a means to restore connections after ... a key molecule that directly regulates nerve cell growth ... in the prestigious journal Nature Communications , with ... "We made the surprising discovery that a protein ...
(Date:4/21/2014)... ROCHESTER, Minn. Acute respiratory distress syndrome is ... Patients who develop the lung disorder postoperatively are ... and those who survive the syndrome may still ... A Mayo Clinic-led study is helping physicians better ... toward preventing this dangerous and costly surgical complication. ...
Breaking Medicine News(10 mins):Health News:Child's autism risk accelerates with mother's age over 30 2Health News:Child's autism risk accelerates with mother's age over 30 3Health News:FDA approves first targeted drug for advanced stomach cancer 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:Scientists discover a new way to enhance nerve growth following injury 2Health News:Acute respiratory distress syndrome: Study IDs surgical patients at risk 2
... that Snake Bites are Becoming More Powerful and Patient Reactions ... marks a change in rattlesnake behavior as well. Snakes ... the rattlesnake is. In humans, a rattlesnake bite can ... the past couple of years we have seen an increase ...
... 5 Argus Health Systems, Inc., a leading provider ... Topor has been elected to the National Council for ... three-year term. The Board of Trustees oversees all Council ... development activities. Prior to the election, Topor, a 12-year ...
... support the use of lower cost sharing as an incentive ... in order to reduce costs, according to survey data published ... have been interested in bringing aspects of "consumerism" into health ... 2009 EBRI Notes , which reports the survey data. ...
... aggressive goals to expand nationwide, Wellspring ... Development. Bill will spearhead the newly formed Network Development Division ... in 2010. He is responsible for making Wellspring a household ... former Fortune 100 senior executive with healthcare, insurance and leading ...
... revenues grow by 31% and gross profit increases 85%ROCHESTER, N.Y., ... a leading provider of quantitative imaging for clinical trials, announced ... over $2.1 million, a 31% increase over prior year,s first ... was $1,119,786 compared to $604,119 in the first quarter of ...
... Advisory Board Will Host ,Day of Dialogue, Online Town Hall ... 5, 2009 America,s healthcare and long-term services need to ... of today,s seniors and people with disabilities, according to a ... The report, which will be supported by a nationwide ...
Cached Medicine News:Health News:As the Weather Warms Up Rattlesnakes Come Out to Enjoy the Sun Just as Californians Do 2Health News:New Research from EBRI: Many Support Lower Cost Sharing to Change Health Care System Use 2Health News:Wellspring Hires William Young and Prepares for Nationwide Expansion 2Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 2Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 3Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 4Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 5Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 6Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 2Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 3
PremierEdge Stab Knives - 15....
DCR Set, Straight....
... CORNEO-GAGE PLUS pachometers are acknowledged to be ... measurement-reproducible pachometers available. These benefits are due ... transducers and smallest tip footprint available coupled ... average for every displayed reading. Thus corneal ...
... Leica CM1850 cryostat for standard ... laboratory is designed for easy ... A new insulation technology used, ... refrigerating system and maintains stable ...
Medicine Products: